254 related articles for article (PubMed ID: 25328065)
21. Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin.
Wenzel J; Tomiuk S; Zahn S; Küsters D; Vahsen A; Wiechert A; Mikus S; Birth M; Scheler M; von Bubnoff D; Baron JM; Merk HF; Mauch C; Krieg T; Bieber T; Bosio A; Hofmann K; Tüting T; Peters B
Int J Cancer; 2008 Dec; 123(11):2605-15. PubMed ID: 18770863
[TBL] [Abstract][Full Text] [Related]
22. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Alterations in Keratinocyte Carcinoma.
Yao Q; Epstein CB; Banskota S; Issner R; Kim Y; Bernstein BE; Pinello L; Asgari MM
J Invest Dermatol; 2021 May; 141(5):1207-1218. PubMed ID: 33212152
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
26. Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin.
Rizzato C; Canzian F; Rudnai P; Gurzau E; Stein A; Koppova K; Hemminki K; Kumar R; Campa D
Carcinogenesis; 2011 Dec; 32(12):1849-54. PubMed ID: 21880580
[TBL] [Abstract][Full Text] [Related]
27. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
Plesko I; Severi G; Obsitníková A; Boyle P
Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
[TBL] [Abstract][Full Text] [Related]
28. Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: a genomic approach.
Heller ER; Gor A; Wang D; Hu Q; Lucchese A; Kanduc D; Katdare M; Liu S; Sinha AA
Int J Oncol; 2013 Feb; 42(2):583-96. PubMed ID: 23229765
[TBL] [Abstract][Full Text] [Related]
29. NAV3 copy number changes and target genes in basal and squamous cell cancers.
Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
[TBL] [Abstract][Full Text] [Related]
30. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
31. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma.
Bäckvall H; Asplund A; Gustafsson A; Sivertsson A; Lundeberg J; Ponten F
Mutat Res; 2005 Apr; 571(1-2):65-79. PubMed ID: 15748639
[TBL] [Abstract][Full Text] [Related]
32. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
33. Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma.
Li ZJ; Mack SC; Mak TH; Angers S; Taylor MD; Hui CC
Oncogene; 2014 May; 33(20):2674-80. PubMed ID: 23752195
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.
Brinkhuizen T; van den Hurk K; Winnepenninckx VJ; de Hoon JP; van Marion AM; Veeck J; van Engeland M; van Steensel MA
PLoS One; 2012; 7(12):e51710. PubMed ID: 23284750
[TBL] [Abstract][Full Text] [Related]
35. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.
Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F
Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575
[TBL] [Abstract][Full Text] [Related]
36. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
37. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
[TBL] [Abstract][Full Text] [Related]
38. Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics.
Bisceglia M; Panniello G; Galliani CA; Centola M; D'Errico MM; Minenna E; Tucci FA; Ben-Dor DJ
Adv Anat Pathol; 2020 Sep; 27(5):331-353. PubMed ID: 32618586
[TBL] [Abstract][Full Text] [Related]
39. Lack of increased P15INK4B protein expression in basal cell carcinomas.
Moad AI; Tan ML; Kaur G; Mabruk M
Asian Pac J Cancer Prev; 2012; 13(12):6239-44. PubMed ID: 23464438
[TBL] [Abstract][Full Text] [Related]
40. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
